Event Date/Time: Nov 30, 2004
End Date/Time: Dec 03, 2004
IBC’s 2nd International Antibody Therapeutics conference covers key aspects of the development of antibodies as therapeutic products, including: capital market, clinical trials and regulatory environment; business development, technology transfer and partnering strategies; technology highlights; clinical study status of pre-clinical and clinical development of recombinant antibodies; production; and a panel discussion covering complex intellectual property issues of the antibody sector. IBC’s 2nd Antibody Therapeutics is co-located with IBC’s 15th Antibody Engineering conference, which gives attendees access to selected sessions at the Antibody Engineering conference and full access to the shared exhibit and poster hall and networking functions. To register for Antibody Therapeutics, visit www.IBCLifeSciences.com/3062 or call IBC at +1-508-616-5550 x1004.